Dr. Reddy's Laboratories Share Price
1185.00+10.00 (+0.85%)
-10.34% past 1 Year
Corporate filings & documents
Announcements
Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015
2 days agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2015
2 days agoClarification- Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015
2 days agoClarification- Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015
2 days agoThe Exchange has sought clarification from Dr Reddys Laboratories Ltd on September 17 2026 with reference to news appeared in https://pharma.economictimes.indiatimes.com/ dated September 17 2026 quoting "Dr Reddys gets voluntary licence for Gileads once-yearly HIV prevention drug"<BR><BR>The reply is awaited.
3 days agoThe Exchange has sought clarification from Dr Reddys Laboratories Ltd on September 17 2026 with reference to news appeared in https://pharma.economictimes.indiatimes.com/ dated September 17 2026 quoting "Dr Reddys gets voluntary licence for Gileads once-yearly HIV prevention drug"<BR><BR>The reply is awaited.
3 days agoCopies of newspaper publication
4 days agoCopies of newspaper publication
4 days agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2015
1 week agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2015
1 week agoAllotment of Employee Stock options
1 week agoAllotment of Employee Stock options
1 week agoIntimation of Analyst meet
1 week agoIntimation of Analyst meet
1 week agoAllotment of Employee Stock options
3 weeks agoAllotment of Employee Stock options
3 weeks agoCopies of newspaper publication
1 month agoCopies of newspaper publication
1 month agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2015
1 month agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2015
1 month agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for ICICI Prudential Mutual Fund
1 month agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for ICICI Prudential Mutual Fund
1 month agoChange in Senior Management Personnel
1 month agoChange in Senior Management Personnel
1 month agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2105
1 month agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2105
1 month agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2015
1 month agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2015- Press Release
1 month agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2015- Press Release
1 month agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2015
1 month agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2015
1 month agoClarification- Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015
1 month agoClarification- Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015
1 month agoTranscript of Earnings call recording
1 month agoThe Exchange has sought clarification from Dr Reddys Laboratories Ltd with reference to the media report appearing on https://www.business-standard.com dated July 28 2026 (Link:https://www.business-standard.com/companies/news/dr-reddys-first-in-class-gonorrhoea-drug-gets-thailand-approval-after-us-nod-126072700632_1.html) titled "Dr Reddys antibiotic gets Thailand approval six months after US nod".<BR><BR>The Company is requested to submit its clarification to the Exchange in terms of the provisions of Regulation 30 of the SEBI (LODR) Regulations 2015.
1 month agoThe Exchange has sought clarification from Dr Reddys Laboratories Ltd with reference to the media report appearing on https://www.business-standard.com dated July 28 2026 (Link:https://www.business-standard.com/companies/news/dr-reddys-first-in-class-gonorrhoea-drug-gets-thailand-approval-after-us-nod-126072700632_1.html) titled "Dr Reddys antibiotic gets Thailand approval six months after US nod".<BR><BR>The Company is requested to submit its clarification to the Exchange in terms of the provisions of Regulation 30 of the SEBI (LODR) Regulations 2015.
1 month agoDisclosure under Regulation 30 of SEBI (LODR) Regulation 2015
1 month agoDisclosure under Regulation 30 of SEBI (LODR) Regulation 2015
1 month agoScrutinizers Report
1 month agoScrutinizers Report
1 month agoOutcome of 42nd Annual General Meeting
1 month agoOutcome of 42nd Annual General Meeting
1 month agoCopy of newspaper publication
1 month agoCopy of newspaper publication
1 month agoIntimation of Earnings call recordings
1 month agoIntimation of Earnings call recordings
1 month agoCopy of Investor Presentation
2 months agoCopy of Investor Presentation
2 months agoGrant of Employee Stock Options
2 months agoGrant of Employee Stock Options
2 months agoConcalls & investor presentations
Jul 2026
May 2026
Jan 2026
Oct 2025
ConcallPresentation
Jul 2025
May 2025
ConcallPresentation
Jan 2025
ConcallPresentation
Nov 2024
ConcallPresentation
Jul 2024
ConcallPresentation
May 2024
ConcallPresentation
Jan 2024
ConcallPresentation
Oct 2023
ConcallPresentation
Jul 2023
ConcallPresentation
May 2023
ConcallPresentation
Jan 2023
ConcallPresentation
Oct 2022
ConcallPresentation
Jul 2022
ConcallPresentation
May 2022
Jan 2022
Oct 2021
Jul 2021
May 2021
Jan 2021
Oct 2020